| The system will be available in the United States in the second half of 2012 INDIANAPOLIS, July 18, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Accu-Chek Combo system for insulin pump therapy. The Accu-Chek Combo system seamlessly combines a blood glucose meter with an insulin pump, which are able to exchange data in both directions via Bluetooth wireless technology. The meter not only...continued RHHBY roche mexoryl disclaimer |
Wednesday, July 18, 2012
FDA clears Accu-Chek Combo system - Roche's new interactive insulin pump system for people with diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment